本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ventyx Biosciences, Inc.

2.08
+0.06002.97%
盘后2.04-0.0400-1.92%16:42 EDT
成交量:87.36万
成交额:177.32万
市值:1.48亿
市盈率:-1.19
高:2.08
开:2.06
低:1.99
收:2.02
数据加载中...
2023/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/11

重要事件披露

Form 8-K - Current report
2023/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/26

重要事件披露

Form 8-K - Current report
2023/07/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/07/11

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/07/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities